Moshe Talpaz
The University of Texas MD Anderson Cancer Center
1 paper in the Anchorcite directory, published in 2001, cited 5,306 times in total.
ORCID profileResearch topics
- Chronic Lymphocytic Leukemia Research · 1 paper
- Chronic Myeloid Leukemia Treatments · 1 paper
- Protein Tyrosine Phosphatases · 1 paper
Frequent co-authors
- Brian J. Druker · 1 paper
- Debra J. Resta · 1 paper
- Bin Peng · 1 paper
- Elisabeth Buchdunger · 1 paper
- J. Ford · 1 paper
- Nicholas Lydon · 1 paper
- Hagop M. Kantarjian · 1 paper
- Renaud Capdeville · 1 paper
Papers
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine · 2001 · 5,306 citations
BACKGROUND: BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of the kinase could be an effective treatment for CML. METHODS: We…
Metadata from OpenAlex (CC0).